In this episode, Keith R. McCrae, MD; Nichola Cooper, MD; and Rachael Grace, MD, MMSc,provide expert insights on immune thrombocytopenia management, along with addressing frequently asked questions from a live CCO symposium. Topics include:New and emerging therapeutic optionsSpecial patient populations, including childrenThe management of immune thrombocytopeniaCOVID-19 vaccinations and immune thrombocytopeniaPresenters:Keith R. McCrae, MDProfessor of Molecular MedicineDepartment of Hematology and OncologyTaussig Cancer InstituteCleveland ClinicCleveland, Ohio, USANichola Cooper, MDHonorary Consultant HematologistHammersmith HospitalImperial CollegeLondon, United KingdomRachael Grace, MD, MMScAssociate Professor of PediatricsHarvard Medical SchoolDana-Farber/Boston Children’s Cancer and Blood Disorders CenterBoston, Massachusetts, USAContent based on an online CME program supported by an educational grant from Amgen; Dova Pharmaceuticals, Inc.; and Sanofi Genzyme.Advances in Immune Thrombocytopenia:https://bit.ly/3gzykzy

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related